SCHEDULE: JW Asset Management Discloses Stake in Establishment Labs

JW Asset Management, along with affiliated entities, has reported beneficial ownership of 9.15% of Establishment Labs Holdings, Inc. common stock as of June 30, 2026.

Summary

• JW Asset Management, LLC, and its affiliates JW Partners, LP, JW Opportunities Fund, LLC, JW GP, LLC, and Jason G. Wild have collectively disclosed their beneficial ownership of Establishment Labs Holdings, Inc. common stock.
• As of June 30, 2026, the total beneficial ownership reported is 2,692,856 shares, representing 9.15% of the outstanding common stock.
• This filing is a Schedule 13G, indicating that the reporting persons are passive investors.
• The total number of shares reported by JW Asset Management, LLC is 2,692,856 (9.15%).
• JW Partners, LP reported beneficial ownership of 2,006,252 shares (6.82%).
• JW Opportunities Fund, LLC reported beneficial ownership of 686,604 shares (2.33%).
• Jason G. Wild reported beneficial ownership of 2,692,856 shares (9.15%).
• The percentage ownership is based on 29,430,390 outstanding shares as of May 7, 2026.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it primarily reports ownership changes and does not provide operational or financial performance details.

Positives

• Significant stake acquired by JW Asset Management and affiliates, potentially indicating confidence in Establishment Labs' future prospects.
• Passive investment status suggests a long-term, non-activist approach to the holding.

Negatives

• No specific financial performance data or operational updates are provided in this filing, limiting the assessment of the company's current health.

Risks

• The filing does not detail specific risks associated with the investment or the company's operations.

Future Outlook

This filing is a Schedule 13G, which reports passive ownership stakes and does not contain forward-looking statements or company guidance.

Industry Context

StockSavvy.ai notes that significant stake disclosures by investment management firms like JW Asset Management are common in the healthcare and medical device sectors, often signaling a belief in the company's growth trajectory or market position.

Stakeholder Impact

• Shareholders: The acquisition of a significant stake by JW Asset Management may be viewed positively, potentially leading to increased investor interest or future strategic involvement.

Key Dates

Keywords

Establishment Labs Holdings, JW Asset Management, Schedule 13G, Beneficial Ownership, Common Stock, Investment Holding, Securities Exchange Act